SIPP Industries Announces Milestone Achievements in Partnership with Calypso Pharmaceuticals
SIPP Industries (OTC PINK:SIPC) announces significant milestones in partnership with Calypso Pharmaceuticals. The company has secured key distributors and retail storefronts in Dallas and Fort Worth, Texas, for their cannabis-based products. These include Calypso Farms THCa Flower/Pre-Rolls, 100mg hemp-derived Delta-9 White Lightning Syringes, and AVEINA 1000mg CBD Infused Body Lotion.
A new production partnership with CHLL Brand will launch innovative products like a 100mg Delta-9 Hemp Derived Water Soluble Flavor Enhancer and a 12oz 25mg CBD Infused Flavorless Bottle of Water. SIPP Industries anticipates booking revenues this quarter, with strong sales expected in Q4 and Q1 2025.
SIPP Industries (OTC PINK:SIPC) annuncia importanti traguardi in collaborazione con Calypso Pharmaceuticals. L'azienda ha ottenuto distributori chiave e negozi al dettaglio a Dallas e Fort Worth, Texas, per i loro prodotti a base di cannabis. Questi includono Calypso Farms THCa Flower/Pre-Rolls, Siringhe Delta-9 White Lightning da 100mg derivate dalla canapa e Crema corpo AVEINA 1000mg Infusa con CBD.
Una nuova partnership produttiva con CHLL Brand lancerà prodotti innovativi come un Aggiuntore di sapore solubile in acqua da 100mg derivato da Delta-9 Hemp e una bottiglia d'acqua da 12oz infusa con 25mg di CBD senza sapore. SIPP Industries prevede di registrare ricavi questo trimestre, con forti vendite attese nel Q4 e Q1 2025.
SIPP Industries (OTC PINK:SIPC) anuncia hitos importantes en asociación con Calypso Pharmaceuticals. La compañía ha asegurado distribuidores clave y tiendas minoristas en Dallas y Fort Worth, Texas, para sus productos a base de cannabis. Estos incluyen Calypso Farms THCa Flower/Pre-Rolls, Siringas Delta-9 White Lightning de 100mg derivadas del cáñamo y Loción corporal AVEINA 1000mg Infundida con CBD.
Una nueva asociación de producción con CHLL Brand lanzará productos innovadores como un Mejorador de sabor soluble en agua de 100mg derivado de Delta-9 Hemp y una botella de agua de 12oz infundida con 25mg de CBD sin sabor. SIPP Industries anticipa registrar ingresos este trimestre, con fuertes ventas esperadas en el Q4 y Q1 de 2025.
SIPP Industries (OTC PINK:SIPC)는 Calypso Pharmaceuticals와의 파트너십으로 중요한 이정표를 발표했습니다. 이 회사는 텍사스의 달라스와 포트워스에서 자사 대마 기반 제품의 주요 유통업체 및 소매점을 확보했습니다. 여기에는 Calypso Farms THCa Flower/Pre-Rolls, 100mg 대마에서 추출한 Delta-9 White Lightning 주사기, AVEINA 1000mg CBD 인퓨즈 바디 로션이 포함됩니다.
CHLL Brand와의 새로운 생산 파트너십을 통해 100mg Delta-9 대마 기반 수용성 향미 강화제와 12oz에 25mg CBD가 주입된 무맛 생수와 같은 혁신적인 제품이 출시될 예정입니다. SIPP Industries는 이번 분기 수익을 기록할 것으로 예상하며, 4분기와 2025년 1분기 강력한 판매를 기대하고 있습니다.
SIPP Industries (OTC PINK:SIPC) annonce des jalons importants en partenariat avec Calypso Pharmaceuticals. L'entreprise a sécurisé des distributeurs clés et des magasins de détail à Dallas et Fort Worth, Texas, pour ses produits à base de cannabis. Ceux-ci incluent Calypso Farms THCa Flower/Pre-Rolls, Seringues Delta-9 White Lightning de 100mg dérivées du chanvre et Crème corporelle AVEINA 1000mg infusée au CBD.
Un nouveau partenariat de production avec CHLL Brand lancera des produits innovants tels qu'un Améliorateur de saveur soluble dans l'eau de 100mg dérivé du chanvre Delta-9 et une bouteille d'eau de 12oz infusée avec 25mg de CBD sans saveur. SIPP Industries s'attend à enregistrer des revenus ce trimestre, avec des ventes élevées attendues au quatrième trimestre et au premier trimestre 2025.
SIPP Industries (OTC PINK:SIPC) gibt bedeutende Meilensteine in Partnerschaft mit Calypso Pharmaceuticals bekannt. Das Unternehmen hat sich wichtige Vertriebspartner und Einzelhandelsgeschäfte in Dallas und Fort Worth, Texas, für ihre Cannabis-basierten Produkte gesichert. Dazu gehören Calypso Farms THCa Flower/Pre-Rolls, 100mg cannabis-basiertes Delta-9 White Lightning Spritzen und AVEINA 1000mg CBD-infudierte Körperlotion.
Eine neue Produktionspartnerschaft mit CHLL Brand wird innovative Produkte wie einen 100mg Delta-9 cannabis-basierten wasserlöslichen Geschmacksverstärker und eine 12oz-Flasche Wasser mit 25mg CBD ohne Geschmack herausbringen. SIPP Industries erwartet, in diesem Quartal Einnahmen zu verbuchen, mit starken Verkäufen im Q4 und Q1 2025.
- Secured key distributors and multi-location retail storefronts in Dallas and Fort Worth
- Launching new production partnership with CHLL Brand for innovative cannabis-based products
- Anticipating booking revenues in the current quarter
- Expecting robust sales in Q4 and Q1 2025
- None.
COSTA MESA, CA / ACCESSWIRE / August 1, 2024 / SIPP Industries, Inc. (OTC PINK:SIPC), a multifaceted corporation specializing in the manufacturing and distribution of commercial and consumer products within the cannabis industry, proudly announces successful distribution and production milestones in collaboration with its partner, Calypso Pharmaceuticals.
SIPP Industries and Calypso Pharmaceuticals have gained significant momentum within the Texas Hemp Industry by securing multiple key distributors and high-volume, multi-location retail storefronts in Dallas and Fort Worth. These outlets will carry an extensive range of products, including the entire lineup of Calypso Farms THCa Flower/Pre-Rolls, Calypso Pharmaceuticals 100mg hemp-derived Delta-9 White Lightning Syringes, and AVEINA 1000mg CBD Infused Body Lotion.
Additionally, SIPP Industries and Calypso Pharmaceuticals is set to launch a new production partnership with CHLL Brand, offering innovative products like a 100mg Delta-9 Hemp Derived Water Soluble Flavor Enhancer and a 12oz 25mg CBD Infused Flavorless Bottle of Water.
The Water Soluble Flavor Enhancer, utilizing a 1:1 ratio of CBD to hemp derived Delta-9, is designed to assist with anxiety and depression. The CBD's anxiolytic effects may help alleviate anxiety symptoms, while Delta-9 could contribute to mood regulation, offering a balanced approach to mental well-being.
The Flavorless Bottle of Water, containing 25mg of CBD per bottle, provides a convenient way to incorporate CBD into daily routines, potentially offering general wellness benefits, including stress relief and relaxation without the psychoactive effects of THC, catering to those seeking a mild, non-intoxicating option.
With the rapid increase in volume and growth, SIPP Industries anticipates booking revenues during this quarter, with robust sales expected to commence in both Q4 and Q1 2025.
Adam Graziano, CEO of SIPP Industries, expressed his excitement about the Company's achievements: "This milestone marks a significant step forward for SIPP Industries and our partner, Calypso Pharmaceuticals. Our commitment to delivering high-quality cannabis-based products continues to drive our success in the market. We are thrilled to expand our offerings and reach more consumers, providing innovative solutions for health and wellness."
About SIPP Industries
SIPP Industries is a multifaceted corporation specializing in the manufacturing and distribution of commercial and consumer products within the cannabis industry.
Website: https://www.sippindustries.com
Facebook: https://www.facebook.com/SippIndustries
X: @SippIndustries
About Calypso Pharmaceuticals
Calypso Pharmaceuticals, based in Dallas, Texas, is on a mission to establish a leading global brand with the most comprehensive portfolio of innovative cannabis-based therapeutics.
The company is dedicated to creating products that ensure a healthy and comfortable life, formulating a wide range of medications for chronic conditions such as Alzheimer's, anxiety, chronic pain, depression, melanoma, obesity, and more. Calypso Pharmaceuticals aims to provide a calm and satisfactory experience in administering and utilizing cannabis-based medicine.
Forward Looking Statements:
This release contains forward-looking statements within the meaning of Section 27a of the Securities Act of 1933, as amended and section 21e of the Securities and Exchange Act of 1934, as amended. Those statements include the intent, belief or current expectations of the Company and its management team. Forward-looking statements are projections of events, revenues, income, future economics, research, development, reformulation, product performance or management's plans and objectives for future operations. Some or all of the events or results anticipated by these forward-looking statements may not occur. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. Accomplishing the strategy described herein is significantly dependent upon numerous factors, many that are not in management's control.
Contact:
Sipp Industries, Inc.
Investor Relations
ir@sippindustries.com
SOURCE: Sipp Industries Inc.
View the original press release on accesswire.com
FAQ
What new products is SIPP Industries (SIPC) launching with CHLL Brand?
Where has SIPP Industries (SIPC) secured new distribution channels?
When does SIPP Industries (SIPC) expect to start booking revenues from these new developments?
What products will be distributed through the new channels secured by SIPP Industries (SIPC)?
